Libra Pharm

Paediatric Clinical Neurology

Book Description

ISBN-10: 1840761342 | ISBN-13: 978-1840761344 | Publication Date: November 1, 2011 | Edition: 1
The past 40 years have seen remarkable advances in pediatric neurology and in many interfacing disciplines, especially medical imaging, genetics and infectious diseases. Yet the fundamentals of neurological examination and history remain essential in the accurate diagnosis of conditions affecting the child’s nervous system. This book begins with a detailed discussion of neurological examination techniques. It covers the basic formulation of differential diagnoses and management using neuroradiology, electrophysiology, genetic and metabolic testing, including sampling cerebrospinal fluids, which is essential in the diagnosis and management of infectious conditions. This second section follows a problem-based approach that takes into account how diseases present in the real world. It employs practical, symptom- and sign-based strategies for virtually all conditions encountered by the practitioner. Throughout the authors emphasize patterns of disease and how recognizing them can be the first step to successful management of a child with a neurological problem. The text concludes with a detailed discussion of neurological emergencies, keeping in mind that such conditions often present first to someone other than to a pediatric neurologist. The book will be of interest to pediatric neurologists, pediatricians, primary care physicians, and emergency physicians in training and practice. Read More….

Basic and Clinical Pharmacology, 11th Edition

Book Description

ISBN-10: 0071604057 | ISBN-13: 978-0071604055 | Publication Date: July 1, 2009 | Edition: 11

The most trusted and up-to-date pharmacology text in medicine — completely redesigned to make the learning process even more interesting and efficient

A Doody’s Core Title ESSENTIAL PURCHASE for 2011!

5 Star Doody’s Review!
“This is the most widely used textbook for teaching pharmacology to health professionals. This 11th edition is far superior to any previous editions….The authors’ goals are to provide a complete, authoritative, current, and readable textbook of pharmacology for students in health sciences. Testimony to their success is the widespread use of this work as required textbook for pharmacology courses around the world. This book is used extensively by thousands of medical, pharmacy, podiatry, nursing, and other health professions students to study pharmacology. Likewise, it remains a valuable resource for residents and practicing physicians….I continue to use this book as a required resource for all courses that I teach to medical, nursing, and allied health students. It is authoritative, readable, and supported by numerous learning tools.”–Doody’s Review Service

Organized to reflect the syllabi in Pharmacology courses, Basic & Clinical Pharmacology covers all the important concepts students need to know about the science of pharmacology and its application to clinical practice. It is acknowledged worldwide as the field’s most current, authoritative, and comprehensive textbook. To be as clinically relevant as possible, the book features a strong focus on the choice and use of drugs in patients and the monitoring of their effects. Read More…

Related News

Top ranking colleges in Pharmacy

According to the Academic Ranking of World Universities published by the Institute of Higher Education at the Shanghai Jiao Tong  University, Harvard University is ranked Number One among the world’s top 100 institutions for Clinical Medicine and Pharmacy in 2009, followed by UC San Francisco (2nd) and University of Washington (3rd). ARWU Top 50 Institutions for Clinical Medicine and Pharmacy (2009): 1 Harvard University 2 University of California, San Francisco 3 University of Washington 4 The Johns Hopkins University 5 Columbia University 6 University of California, Los Angeles 7 The University of Texas Southwestern Medical Center at Dallas 8 Karolinska Institute 8 University of Michigan – Ann Arbor 10 University College London 11 Stanford University 12 University of Pittsburgh 13 University of Oxford 14 Mayo Medical School 15 University of Cambridge 16 University of Minnesota, Twin Cities 17 University of North Carolina at Chapel Hill 18 Vanderbilt University 19 The University… More

What is Pharmacology?

Pharmacology is the study of drugs and how they affect the body. Pharmacology, which often refers to creating new chemical substances and analyzing the effects of established medicinal compounds, can also apply to the practice of looking at how harmful drugs affect the individual. Pharmacology involves elements of toxicology, biology, chemistry, and physiology, and is a broad scientific field applicable to many careers in the life sciences area. To find out more about the difference between pharmacy and pharmacology click here and visit this careers website to study pharmacology in the UK . Universities in America also offer degrees in pharmacology. Non-US citizens traveling to the United States for educational or recreational purposes need health insurance from a recognized provider. A popular affordable option is available at inboundusainsurance.net It is important to note the difference between the studies of pharmacy and pharmacology…. More

Latest News from Pharma Industry:

  • Omega-3 fatty acids and vitamin D may control brain serotonin

    Although essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the context of certain brain disorders, the underlying mechanism has been unclear. In a new paper published in FASEB Journal by Rhonda Patrick, PhD and Bruce Ames, PhD of Children's Hospital Oakland Research Institute (CHORI), serotonin is explained as the possible missing link tying together why vitamin D and marine omega-3 fatty acids might ameliorate the symptoms associated with a broad array of brain disorders.
  • Graphene shows potential as novel anti-cancer therapeutic strategy

    University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This new development opens up the possibility of preventing or treating a broad range of cancers, using a non-toxic material. Writing in the journal Oncotarget, the team of researchers led by Professor Michael Lisanti and Dr Aravind Vijayaraghavan has shown that graphene oxide, a modified form of graphene, acts as an anti-cancer agent that selectively targets cancer stem cells (CSCs).
  • Shire acquires Meritage Pharma

    ShireShire plc (LSE: SHP, NASDAQ: SHPG) and Meritage Pharma, Inc. announced today that Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.
  • Novartis receives FDA approval of Farydak®, the first HDAC inhibitor for patients with multiple myeloma

    NovartisNovartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat, previously known as LBH589) capsules in combination with bortezomib* and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior regimens, including bortezomib and an immunomodulatory (IMiD) agent[1].
  • Safety and life-saving efficacy of statins have been exaggerated

    Hailed as miracle drugs when they hit the market two decades ago, statins, the cholesterol-lowering drugs prescribed to prevent heart attacks, are not as effective nor as safe as we have been led to believe, say Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida, and Dr. Uffe Ravnskov, an independent health researcher and an expert in cholesterol and cardiovascular disease.